The effect of protamine on the epicardial microflow and the graft flow in open-heart surgery

Perfusion

Volumn 12, Issue 2, 1997, Pages 99-106

  Belboul, Ali ^a   Al Khaja, Najib ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PROTAMINE;

ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; DOPPLER FLOWMETRY; ELECTROMAGNETIC FLOWMETER; EPICARDIUM; FEMALE; HEART LEFT VENTRICLE; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HEART VALVE REPLACEMENT; HUMAN; LASER DOPPLER FLOWMETRY; MALE; MICROCIRCULATION; OPEN HEART SURGERY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

EID: 0030969266     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/026765919701200204     Document Type: Article

References (43)

1. Hartley CJ, Cole JS. An ultrasonic pulsed Doppler system for measuring blood flow in small vessels. J Appl Physiol 1974; 37: 626.
2. Tomonaga G, Mitake H, Hoki N et al. Measurement of point velocity in the canine coronary artery by laser Doppler velocimeter with optical fiber. Jpn J Snrg 1981; 11: 226.
3. McLean J. The thromboplastic action of cephalin. Am J Physiol 1916; 41: 250-52.
4. Chargoff F, Olson KB. Studies on the chemistry of blood coagulation. VI. Studies on the action of heparin and other anticoagulants. The influence of protamine on the anticoagulant effect in vivo. J Biol Chem 1937-38; 122: 153-67.
5. Horrow JC. Protamine: a review of its toxicity. Anesth Analg 1985; 64: 348-81.
6. Lowenstein E, Zapol WM. Protamine reaction, explosive mediator release, and pulmonary vasoconstriction [Editorial]. Anesthesiology 1990; 73: 373-75.
7. Hobbhahn J, Conzen PF, Zenker B, Goetz AE, Peter K, Brendel W. Beneficial effect of cyclooxygenase inhibition on adverse hemodynamic responses after protamine. Anesth Analg 1988; 67: 253-60.
8. Hines RL, Brash PG: Protamine: does it alter right ventricular function? Anesth Analg 1986, 65: 1271-74.
9. Wakefield TW, Till GO, Lindblad B, Saenz N, Stanley JC. Complement depletion and persistent hemodynamic-hematologic responses in protamine-heparin reactions. J Surg Res 1988; 45: 320-26.
10. Morel DR, Zapol WM, Thomas SJ et al. C5a and thromboxane generation associated with pulmonary vaso- and broncho-constriction during protamine reversal of heparin. Anesthesiology 1987; 66: 597-604.
11. Lindblad B, Wakefield TW, Whitehouse WM, Stanley JC. The effect of protamine sulfate on platelet function. Scand J Thorac Cardiovasc Surg 1988; 22: 55-59.
12. Nilsson GE, Tenland T, Öberg PÅ. Evaluation of laser Doppler flowmeter for measurement of tissue blood flow. IEEE Trans Biomed Eng (BME) 1980; 27: 597-604.
13. Louagie Yves AG, Haxhe JP, Buche M, Schoevaerdts JC. Intraoperative electromagnetic flowmeter measurements in coronary artery bypass grafts. Ann Thorac Surg 1994; 57: 357-64.
14. Damber JE, Lindahl O, Selstam G, Tenland T. Rhythmical oscillations in rat testicular microcirculation as recorded by laser Doppler flowmeter. Acta Physiol 1983; 118: 117-23.
15. Hellem S, Jacobsson LS, Nilsson GE, Lewis DH. Measurement of microvascular blood flow in cancerous bone using laser Doppler flowmeter and 133Xe-clearance. Int J Oral Surg 1983; 12: 165-77.
16. Holloway GA, Watkins DW. Laser Doppler measurement of cutaneous blood flow. J Invest Dermatol 1977; 69: 306-309.
17. Jones BM, Bryan JM. The laser Doppler flowmeter for microvascular monitoring: a preliminary report. Br J Plast Reconstr Surg 1982; 35: 147-49.
18. Al-Khaja N, Belboul A, Bergman P, Roberts D, William-Olsson G. Cutaneous microcirculation and blood rheology following cardiopulmonary bypass. Laser Doppler flowmetric and blood cell rheologic studies. Scand J Thorac Cardiovasc Surg 1988; 22: 149-53.
19. Jaques LB. A study of the toxicity of protamine (Salnine). Br J Pharmacol 1949; 4: 135-44.
20. Shapira N, Schaff HV, Piehler JM, White RD, Still JC, Pluth JR. Cardiovascular effects of protamine sulfate in man. J Thorac Cardiovasc Surg 1982; 84: 505-14.
21. Frater RMW, Oka Y, Hong Y, Tsubo T, Loubser PG, Masone R. Protamine-induced circulatory changes. J Thorac Cardiovasc Surg 1984; 87: 687-92.
22. Katz NM, Kim YD, Siegelman R, Ved SA, Ahmed SW, Wallace RB. Hemodynamics of protamine administration. J Thorac Cardiovasc Surg 1987; 94: 881-86.
23. Horrow JC. Protamine: a review of its toxicity. Anesth Analg 1985; 64: 348-61.
24. Procaccini B, Clementi G, Bersanetti L et al. Cardiorespiratory effects of protamine sulfate in man: intra-aortic versus intra-right atrial rapid administration after cardiopulmonary bypass. J Cardiovasc Surg 1987; 28: 112-19.
25. Wakefield TW, Hantler CB, Lindblad B, Whitehouse WM, Stanley JC. Protamine pretreatment attenuation of hemodynamic and hematologic effects of heparine-protamine interaction. J Vasc Surg 1986; 3: 885-89.
26. Kirklin JK, Chenoweth DE, Naftel DC et al. Effects of protamine administration after cardiopulmonary bypass on complement, blood elements, and hemodynamic state. Ann Thorac Surg 1986; 41: 193-99.
27. Chang SW, Westcott JY, Henson JE, Voelkel NF. Pulmonary vascular injury by polycations in perfused rat lungs. J Appl Physiol 1987; 62: 1932-43.
28. Czartolomna JN, Voelkel NF, Chang SW. Permeability characteristics of isolated perfused rat lungs. J Appl Physiol 1991; 70: 1854-60.
29. Sunnergren KP, Fairman RP, Deblois GG, Glauser FL. Effects of protamine, heparinase, and hyaluronidase on endothelial permeability and surface charge. J Appl Physiol 1987; 63: 1987-92.
30. Parker JC, Hernandez LA, Shibamoto T, Coker PJ, Buchanan B. Leukocyte mediation of protamine microvascular damage in dog lungs [Abstract]. Physiologist 1988; 31: A58.
31. Kreil E, Montalescot G, Greene E et al. Nafamsat mesilate attenuates pulmonary hypertension in heparin-protamine reactions. J Appl Physiol 1989; 67: 1463-71.
32. Fernandez HN, Henson PM, Otani A, Hugli TE. Chemotactic response to human C3a and C5a anaphylotoxins: I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions. J Immunol 1978; 130: 109-15.
33. Webster RO, Hong SR, Johnston RB, Henson PM. Biological effects of the human complement fragments C3a and C5a des Arg on neutrophil function. Immunopharmacology 1980; 2: 201-209.
34. Shanberge JN, Murato M, Quattrociocchi-Long T, Neste LV. Heparin-protamine complexes in the production of heparin rebound and other complications of extracorporeal bypass procedures. Am J Clin Pathol 1987; 87: 210-17.
35. Sethna DH, Moffitt E, Gray RJ. Effects of protamine sulfate on myocardial oxygen supply and demand in patients following cardiopulmonary bypass. Anesth Analg 1982; 61: 247-51.
36. Wakefield TW, Hinshaw DB, Burger JM, Burkel WE, Stanley JC. Protamine-induced reductions of endothelial cell ATP. Surgery 1989; 106: 378-85.
37. Housmans PR, Ferguson DM. Inotropic effects of protamine sulfate on isolated mammalian cardiac muscles: mechanisms of action [Abstract]. Anesthesiology 1987; 67: 24.
38. Hendry PJ, Taichman GC, Keon WJ. The myocardial contractile responses to protamine sulfate and heparin. Ann Thorac Surg 1987; 44: 263-68.
39. Iwatsuki N, Matsukawa S, Iwatsuki K. A weak negative inotropic effect of protamine sulfate upon the isolated canine heart muscle. Anesth Analg 1980; 59: 100-102.
40. Caplan RA, Su JY. Differences in threshold for protamine toxicity in isolated atrial and ventricular tissue. Anesth Analg 1984; 63: 1111-15.
41. Popinigis J, Wrzolkowa T, Swierczynski J. Changes in mitochondrial ultrastructure induced by gramacidin plus protamine. Biochem Biophys Acta 1971; 245: 70-79.
42. Nagy Z, Peters H, Huttner I. Endothelial surface charge: blood-brain barrier opening to horseradish peroxidase induced by the polycation protamine sulfate. Acta Neuropathol (Berl) 1981; 7 (suppl.): 7-9.
43. Nagy Z, Peters H, Huttner I. Charge-related alterations of the cerebral endothelium. Lab Invest 1983; 49: 662-71.